Detection of cervical cancer biomarker patterns in blood plasma and urine by differential scanning calorimetry and mass spectrometry

• Published in: PloS one 2014-01, Vol.9 (1), p.e84710
• Main Authors: Garbett, Nichola C, Merchant, Michael L, Helm, C William, Jenson, Alfred B, Klein, Jon B, Chaires, Jonathan B
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; albumins; Amino Acid Sequence; Analysis; BASIC BIOLOGICAL SCIENCES; Bioindicators; Biology; Biomarkers; Biomarkers, Tumor - blood; Biomarkers, Tumor - chemistry; Biomarkers, Tumor - urine; Blood; Blood plasma; Blood proteins; Calorimetry; Calorimetry, Differential Scanning; Cancer; Cancer diagnosis; Cancer research; Cervical cancer; Cervical carcinoma; Change detection; Chemistry; Demographics; Diagnostic software; Diagnostic systems; Differential scanning calorimetry; Disease; Disease Progression; Female; Genomics; Heat measurement; Human papillomavirus; Humans; Identification methods; Invasiveness; Low molecular weights; Mass Spectrometry; Mass spectroscopy; Matrix-assisted laser desorption ionization time-of-flight mass spectrometry; Medical diagnosis; Medicine; Metastasis; Middle Aged; Minority & ethnic groups; Molecular Sequence Data; Molecular weight; Peptides; Physics; Plasma proteins; Principal component analysis; Proteins; Proteomics; Scientific imaging; Smoking; Spectroscopy; Thermodynamic properties; Thermography; Urine; Uterine Cervical Neoplasms - blood; Uterine Cervical Neoplasms - diagnosis; Uterine Cervical Neoplasms - urine; Womens health; Young Adult
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0084710

Improved methods for the accurate identification of both the presence and severity of cervical intraepithelial neoplasia (CIN) and extent of spread of invasive carcinomas of the cervix (IC) are needed. Differential scanning calorimetry (DSC) has recently been shown to detect specific changes in the thermal behavior of blood plasma proteins in several diseases. This methodology is being explored to provide a complementary approach for screening of cervical disease. The present study evaluated the utility of DSC in differentiating between healthy controls, increasing severity of CIN and early and advanced IC. Significant discrimination was apparent relative to the extent of disease with no clear effect of demographic factors such as age, ethnicity, smoking status and parity. Of most clinical relevance, there was strong differentiation of CIN from healthy controls and IC, and amongst patients with IC between FIGO Stage I and advanced cancer. The observed disease-specific changes in DSC profiles (thermograms) were hypothesized to reflect differential expression of disease biomarkers that subsequently bound to and affected the thermal behavior of the most abundant plasma proteins. The effect of interacting biomarkers can be inferred from the modulation of thermograms but cannot be directly identified by DSC. To investigate the nature of the proposed interactions, mass spectrometry (MS) analyses were employed. Quantitative assessment of the low molecular weight protein fragments of plasma and urine samples revealed a small list of peptides whose abundance was correlated with the extent of cervical disease, with the most striking plasma peptidome data supporting the interactome theory of peptide portioning to abundant plasma proteins. The combined DSC and MS approach in this study was successful in identifying unique biomarker signatures for cervical cancer and demonstrated the utility of DSC plasma profiles as a complementary diagnostic tool to evaluate cervical cancer health.